Case Study: Verve Therapeutics achieves digital-first QC and faster right-first-time approvals with Veeva Systems

Verve Puts Digital-First Quality at the Heart of Its QC Lab

Verve Therapeutics, a biotech founded in 2018, needed to bring quality control in-house as it moved products into clinical development and wanted a paperless, GMP-compliant lab from the start. To improve efficiency and reduce manual work, Verve chose Veeva Systems’ Veeva LIMS to unify QA and QC, support a cloud-first approach, and replace paper-based and research-centric tools with a more scalable system.

Veeva Systems implemented Veeva LIMS to connect QC, QA, training, and other quality processes on one platform, enabling automated notifications, audit trails, right-version document access, and built-in checks for data integrity. The result is expected to improve right first time and initial approval by reducing transcription and calculation errors, while also speeding sample-to-release workflows, improving adoption, and giving Verve automatic KPI reporting to help identify bottlenecks.

Verve Therapeutics

Por Bjerke

Senior Manager of Quality Control Internal Operations